{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:28:53Z","timestamp":1791246533642,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T00:00:00Z","timestamp":1654992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Cancer Center Research and Development Fund","award":["31-A-25"],"award-info":[{"award-number":["31-A-25"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1245\/s10434-022-11950-1","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T17:02:27Z","timestamp":1655053347000},"page":"7047-7058","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail"],"prefix":"10.1245","volume":"29","author":[{"given":"Kei","family":"Kitamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Esaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Sone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Sugawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Takamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Mizui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,12]]},"reference":[{"issue":"6","key":"11950_CR1","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nrclinonc.2013.66","volume":"10","author":"J Werner","year":"2013","unstructured":"Werner J, Combs SE, Springfeld C, Hartwig W, Hackert T, B\u00fcchler MW. Advanced-stage pancreatic cancer: therapy options. Nat Rev Clin Oncol. 2013;10(6):323\u201333. https:\/\/doi.org\/10.1038\/nrclinonc.2013.66.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10039","key":"11950_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73\u201385. https:\/\/doi.org\/10.1016\/s0140-6736(16)00141-0.","journal-title":"Lancet"},{"key":"11950_CR3","volume-title":"AJCC cancer staging manual","author":"AJCC","year":"2017","unstructured":"AJCC. AJCC cancer staging manual. 8th edn. Springer; 2017.","edition":"8"},{"issue":"4","key":"11950_CR4","doi-asserted-by":"publisher","first-page":"e1000267","DOI":"10.1371\/journal.pmed.1000267","volume":"7","author":"S Gillen","year":"2010","unstructured":"Gillen S, Schuster T, Meyer Zum B\u00fcschenfelde C, Friess H, Kleeff J. Preoperative\/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages. PLoS Med. 2010;7(4):e1000267. https:\/\/doi.org\/10.1371\/journal.pmed.1000267.","journal-title":"PLoS Med"},{"issue":"1","key":"11950_CR5","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejso.2017.10.217","volume":"44","author":"S Crippa","year":"2018","unstructured":"Crippa S, Cirocchi R, Maisonneuve P, et al. Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer. Eur J Surg Oncol. 2018;44(1):24\u201330. https:\/\/doi.org\/10.1016\/j.ejso.2017.10.217.","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"11950_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1245\/s10434-017-6274-8","volume":"25","author":"T Mizumoto","year":"2018","unstructured":"Mizumoto T, Toyama H, Asari S, et al. Pathological and radiological splenic vein involvement are predictors of poor prognosis and early liver metastasis after surgery in patients with pancreatic adenocarcinoma of the body and tail. Ann Surg Oncol. 2018;25(3):638\u201346. https:\/\/doi.org\/10.1245\/s10434-017-6274-8.","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"11950_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/jso.25498","volume":"120","author":"JJ Hyun","year":"2019","unstructured":"Hyun JJ, Rose JB, Alseidi AA, et al. Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland. J Surg Oncol. 2019;120(2):262\u20139. https:\/\/doi.org\/10.1002\/jso.25498.","journal-title":"J Surg Oncol"},{"issue":"3","key":"11950_CR8","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1245\/s10434-020-08922-8","volume":"28","author":"M Kawai","year":"2021","unstructured":"Kawai M, Hirono S, Okada KI, et al. Radiographic splenic artery involvement is a poor prognostic factor in upfront surgery for patients with resectable pancreatic body and tail cancer. Ann Surg Oncol. 2021;28(3):1521\u201332. https:\/\/doi.org\/10.1245\/s10434-020-08922-8.","journal-title":"Ann Surg Oncol"},{"key":"11950_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/bjs\/znab357","author":"JS Kang","year":"2021","unstructured":"Kang JS, Choi YJ, Byun Y, et al. Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival. Br J Surg. 2021. https:\/\/doi.org\/10.1093\/bjs\/znab357.","journal-title":"Br J Surg"},{"issue":"1","key":"11950_CR10","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/j.gastro.2013.11.004","volume":"146","author":"MM Al-Hawary","year":"2014","unstructured":"Al-Hawary MM, Francis IR, Chari ST, et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the society of abdominal radiology and the american pancreatic association. Gastroenterology. 2014;146(1):291-304.e1. https:\/\/doi.org\/10.1053\/j.gastro.2013.11.004.","journal-title":"Gastroenterology"},{"issue":"1","key":"11950_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","volume":"17","author":"AN Kamarudin","year":"2017","unstructured":"Kamarudin AN, Cox T, Kolamunnage-Dona R. Time-dependent ROC curve analysis in medical research: current methods and applications. BMC Med Res Methodol. 2017;17(1):53. https:\/\/doi.org\/10.1186\/s12874-017-0332-6.","journal-title":"BMC Med Res Methodol"},{"issue":"13","key":"11950_CR12","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1245\/s10434-011-1769-1","volume":"18","author":"S Partelli","year":"2011","unstructured":"Partelli S, Crippa S, Barugola G, et al. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection. Ann Surg Oncol. 2011;18(13):3608\u201314. https:\/\/doi.org\/10.1245\/s10434-011-1769-1.","journal-title":"Ann Surg Oncol"},{"key":"11950_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejca.2018.10.008","volume":"106","author":"TM Mackay","year":"2019","unstructured":"Mackay TM, van Erning FN, van der Geest LGM, et al. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis. Eur J Cancer. 2019;106:99\u2013105. https:\/\/doi.org\/10.1016\/j.ejca.2018.10.008.","journal-title":"Eur J Cancer"},{"issue":"3","key":"11950_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.surg.2014.09.022","volume":"157","author":"H Takahashi","year":"2015","unstructured":"Takahashi H, Akita H, Gotoh K, et al. Preoperative gemcitabine-based chemoradiation therapy for pancreatic ductal adenocarcinoma of the body and tail: impact of splenic vessels involvement on operative outcome and pattern of recurrence. Surgery. 2015;157(3):484\u201395. https:\/\/doi.org\/10.1016\/j.surg.2014.09.022.","journal-title":"Surgery"},{"issue":"2","key":"11950_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/sla.0000000000002705","volume":"268","author":"JY Jang","year":"2018","unstructured":"Jang JY, Han Y, Lee H, et al. Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2\/3 trial. Ann Surg. 2018;268(2):215\u201322. https:\/\/doi.org\/10.1097\/sla.0000000000002705.","journal-title":"Ann Surg"},{"issue":"12","key":"11950_CR16","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1056\/NEJMoa032295","volume":"350","author":"JP Neoptolemos","year":"2004","unstructured":"Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350(12):1200\u201310. https:\/\/doi.org\/10.1056\/NEJMoa032295.","journal-title":"N Engl J Med"},{"issue":"14","key":"11950_CR17","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1001\/jama.2013.279201","volume":"310","author":"H Oettle","year":"2013","unstructured":"Oettle H, Neuhaus P, Hochhaus A, et al. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial. JAMA. 2013;310(14):1473\u201381. https:\/\/doi.org\/10.1001\/jama.2013.279201.","journal-title":"JAMA"},{"issue":"10073","key":"11950_CR18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/s0140-6736(16)32409-6","volume":"389","author":"JP Neoptolemos","year":"2017","unstructured":"Neoptolemos JP, Palmer DH, Ghaneh P, et al. Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet. 2017;389(10073):1011\u201324. https:\/\/doi.org\/10.1016\/s0140-6736(16)32409-6.","journal-title":"Lancet"},{"issue":"16","key":"11950_CR19","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1200\/jco.19.02274","volume":"38","author":"E Versteijne","year":"2020","unstructured":"Versteijne E, Suker M, Groothuis K, et al. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: results of the dutch randomized phase III PREOPANC Trial. J Clin Oncol. 2020;38(16):1763\u201373. https:\/\/doi.org\/10.1200\/jco.19.02274.","journal-title":"J Clin Oncol"},{"issue":"2","key":"11950_CR20","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1093\/jjco\/hyy190","volume":"49","author":"F Motoi","year":"2019","unstructured":"Motoi F, Kosuge T, Ueno H, et al. Randomized phase II\/III trial of neoadjuvant chemotherapy with gemcitabine and S-1 versus upfront surgery for resectable pancreatic cancer (Prep-02\/JSAP05). Jpn J Clin Oncol. 2019;49(2):190\u20134. https:\/\/doi.org\/10.1093\/jjco\/hyy190.","journal-title":"Jpn J Clin Oncol"},{"issue":"8","key":"11950_CR21","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1002\/bjs.10870","volume":"105","author":"E Versteijne","year":"2018","unstructured":"Versteijne E, Vogel JA, Besselink MG, et al. Meta-analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer. Br J Surg. 2018;105(8):946\u201358. https:\/\/doi.org\/10.1002\/bjs.10870.","journal-title":"Br J Surg"},{"issue":"6","key":"11950_CR22","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1245\/s10434-019-08137-6","volume":"27","author":"S Lof","year":"2020","unstructured":"Lof S, Korrel M, van Hilst J, et al. Impact of neoadjuvant therapy in resected pancreatic ductal adenocarcinoma of the pancreatic body or tail on surgical and oncological outcome: a propensity-score matched multicenter study. Ann Surg Oncol. 2020;27(6):1986\u201396. https:\/\/doi.org\/10.1245\/s10434-019-08137-6.","journal-title":"Ann Surg Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11950-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-022-11950-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-022-11950-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T15:15:32Z","timestamp":1663773332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-022-11950-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,12]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["11950"],"URL":"https:\/\/doi.org\/10.1245\/s10434-022-11950-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,12]]},"assertion":[{"value":"23 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}